Sergio Vázquez; María José Villanueva; José Luis Fírvida; Begoña Campos; Martín Lázaro; Gerardo Huidobro; María del Carmen Areses; Natalia Fernández; Marta Covela; Joaquín Casal. Erlotinib As Second-Line Therapy for Patients With Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors. J. Anal. Oncol. 2015, 4,  94-101.